Skip to content

CG Oncology

US · CGON #1929 by market cap Listed 2024
79.47 -2.43 -2.97%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)
    TipRanks · 2026/8/7
  • Rating change
    Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $93
    Market Newswire · 2026/8/17
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)
    TipRanks · 2026/8/13
  • Guggenheim Maintains CG Oncology(CGON.US) With Buy Rating, Cuts Target Price to $89
    Market Newswire · 2026/11/9
  • Rating change
    A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $85 to $108
    Market Newswire · 2026/8/8
  • Rating change
    Analysts' Top Healthcare Picks: Annexon Biosciences (ANNX), CG Oncology, Inc. (CGON)
    TipRanks · 2026/8/7
  • Rating change
    Analysts' Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)
    TipRanks · 2026/8/7
  • Wedbush Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $84
    Market Newswire · 2026/11/9
  • Rating change
    A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $79 to $100
    Market Newswire · 2026/8/7
  • JonesTrading Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85
    Market Newswire · 2026/11/7
  • Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Raises Target Price to $102
    Market Newswire · 2026/11/13
  • Rating change
    CG Oncology, Inc. (CGON) Gets a Buy From Piper Sandler
    TipRanks · 2026/8/7
  • Rating change
    CG Oncology, Inc. (CGON) Initiated With a Buy at Guggenheim
    TipRanks · 2026/10/22
  • Rating change
    UBS Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $90
    Market Newswire · 2026/8/21
  • Rating change
    Analysts' Top Healthcare Picks: CG Oncology, Inc. (CGON), Opus Genetics (IRD)
    TipRanks · 2026/9/10
  • Rating change
    LifeSci Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $108
    Market Newswire · 2026/7/28
  • H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $100
    Market Newswire · 2026/11/7
  • Rating change
    UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)
    TipRanks · 2026/8/20
  • Rating change
    Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85
    Market Newswire · 2026/8/13
  • Rating change
    Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating
    Market Newswire · 2026/9/10
  • Rating change
    H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $100
    Market Newswire · 2026/7/29
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)
    TipRanks · 2026/7/28
  • Rating change
    RBC Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $81
    Market Newswire · 2026/6/30
  • Rating change
    Analysts Offer Insights on Healthcare Companies: ATyr Pharma (ATYR) and CG Oncology, Inc. (CGON)
    TipRanks · 2026/7/10
  • Rating change
    Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON), Alnylam Pharma (ALNY) and Connect Biopharma Holdings (CNTB)
    TipRanks · 2026/6/30

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

CG Oncology discussion 0 comments

Add a comment